Combined Mendelian randomization and quantitative proteomics analysis to study the influence of thyroid dysfunction on acute ischemic stroke

Abstract

Acute ischemic stroke (AIS) is characterized by high morbidity and mortality, making it crucial to identify the risk factors that influence its occurrence and prognosis. Although individuals with thyroid dysfunction exhibit altered stroke patterns, evidence from observational studies remains inconsistent. Herein, we investigated the influence of thyroid dysfunction on stroke progression and prognosis. We combined Mendelian randomization (MR) and tandem mass tag (TMT)-based quantitative proteomics analysis to study the influence of thyroid dysfunction on AIS. Differentially expression proteins (DEPs) were subsequently identified, functional enrichment analysis was performed, and a protein–protein interaction (PPI) network was constructed. Protein alterations were further validated by western blot. MR analysis revealed a causal association between thyroid disorders and ischemic stroke. DEP analysis identified 38 downregulated proteins and five upregulated proteins. Functional enrichment analysis and PPI network construction highlighted the importance of immune response activation and acute phase pathways, along with the suppression of focal adhesion, regulation of the actin cytoskeleton, and platelet activation pathways. Vasodilator-stimulated phosphoprotein, MYL12B, MYL6, and TPM4 were identified as key DEPs significantly associated with pathological pathways and were verified by western blot. The identification of these key proteins and pathways provides new perspectives for investigating the progression and prognosis of AIS.

Keywords

acute ischemic stroke / Hashimoto’s thyroiditis / Mendelian randomization / tandem mass tag proteomics / thyroid dysfunction

References

[1] MozaffarianD, Benjamin EJ, GoAS, et al. Heart disease and stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38-e360.

[2] FeiginVL, Nichols E, AlamT, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459-480.

[3] JacobMA, EkkerMS, AllachY, et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults—a worldwide meta-analysis: the GOAL initiative. Neurology. 2022;98(6):e573-e588.

[4] KarchA, ThomasSL. Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study. Neurology. 2014;82(18):1643-1652.

[5] SquizzatoA, GerdesVEA, BrandjesDPM, Büller HR, StamJ. Thyroid diseases and cerebrovascular disease. Stroke. 2005;36(10):2302-2310.

[6] FlynnRWV, Macdonald TM, JungRT, MorrisAD, LeeseGP. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab. 2006;91(6):2159-2164.

[7] MoutzouriE, LykoC, FellerM, et al. Subclinical thyroid function and cardiovascular events in patients with atrial fibrillation. Eur J Endocrinol. 2021;185(3):375-385.

[8] AkhoundiFH, Ghorbani A, SoltaniA, MeysamieA. Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism. Neurology. 2011;77(4):349-354.

[9] DhitalR, PoudelDR, TachamoN, et al. Ischemic stroke and impact of thyroid profile at presentation: a systematic review and meta-analysis of observational studies. J Stroke Cerebrovasc Dis. 2017;26(12):2926-2934.

[10] AlevizakiM, Synetou M, XynosK, AlevizakiCC, VemmosKN. Hypothyroidism as a protective factor in acute stroke patients. Clin Endocrinol. 2006;65(3):369-372.

[11] RastogiL, Godbole MM, RayM, et al. Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult. Exp Neurol. 2006;200(2):290-300.

[12] BaekJH, ChungPW, KimYB, et al. Favorable influence of subclinical hypothyroidism on the functional outcomes in stroke patients. Endocr J. 2010;57(1):23-29.

[13] GörarS, Ademoğlu E, Çarlıoğlu A, et al. Low levels of circulating platelet factor 4 (PF4, CXCL4) in subclinically hypothyroid autoimmune thyroiditis. J Endocrinol Invest. 2016;39(2):185-189.

[14] HomoncikM, GesslA, FerlitschA, Jilma B, VierhapperH. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 2007;92(8):3006-3012.

[15] Mohamud YusufA, Hagemann N, ZhangX, et al. Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles. Basic Res Cardiol. 2022;117(1):43.

[16] GregoriusJ, WangC, StambouliO, et al. Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice. Basic Res Cardiol. 2021;116(1):40.

[17] JiaC, LovinsC, MaloneHM, Keasey MP, HaggT. Female-specific neuroprotection after ischemic stroke by vitronectin-focal adhesion kinase inhibition. J Cereb Blood Flow Metab. 2022;42(10):1961-1974.

[18] BurgessS, FoleyCN, ZuberV. Inferring causal relationships between risk factors and outcomes from genome-wide association study data. Annu Rev Genomics Hum Genet. 2018;19:303-327.

[19] Davey SmithG, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1-22.

[20] StarkK, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666-682.

[21] SchellerI, BeckS, GöbV, et al. Thymosin β4 is essential for thrombus formation by controlling the G-actin/F-actin equilibrium in platelets. Haematologica. 2022;107(12):2846-2858.

[22] ChenZ, LiuP, XiaX, CaoC, DingZ, Li X. Low ambient temperature exposure increases the risk of ischemic stroke by promoting platelet activation. Sci Total Environ. 2024;912:169235.

[23] PenningsGJ, ReddelCJ, ChenVM, Gnanenthiran SR, KritharidesL. Perspective: collagen induced platelet activation via the GPVI receptor as a primary target of colchicine in cardiovascular disease. Front Cardiovasc Med. 2022;9:1104744.

[24] XiaoQ, YinR, WangY, et al. Comprehensive analysis of peripheral exosomal circRNAs in large artery atherosclerotic stroke. Front Cell Dev Biol. 2021;9:685741.

[25] HoltMR, Critchley DR, BrindleNPJ. Molecules in focus the focal adhesion phosphoprotein, VASP. Int J Biochem Cell Biol. 1998;30(3):307-311.

[26] LawrenceDW, Comerford KM, ColganSP. Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am J Physiol-Cell Physiol. 2002;282(6):C1235-C1245.

[27] CollardCD, ParkKA, MontaltoMC, et al. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem. 2002;277(17):14801-14811.

[28] AktasB, UtzA, Hoenig-LiedlP, WalterU, GeigerJ. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke. 2003;34(3):764-769.

[29] PleinesI, WoodsJ, ChappazS, et al. Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia. J Clin Invest. 2017;127(3):814-829.

[30] MalikR, Chauhan G, TraylorM, et al. Multiancestry genome-wide association study of 520, 000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524-537.

[31] Adams Jr.HP, Bendixen BH, KappelleLJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.

[32] LiS, HeY, LinZ, et al. Digging more missing proteins using an enrichment approach with ProteoMiner. J Proteome Res. 2017;16(12):4330-4339.

[33] HartwigS, Czibere A, KotzkaJ, et al. Combinatorial hexapeptide ligand libraries (ProteoMiner): an innovative fractionation tool for differential quantitative clinical proteomics. Arch Physiol Biochem. 2009;115(3):155-160.

[34] LoveMI, HuberW, AndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biol. 2014;15(12):550.

[35] HeH, OlesenCM, PavelAB, et al. Tape-strip proteomic profiling of atopic dermatitis on dupilumab identifies minimally invasive biomarkers. Front Immunol. 2020;11:1768.

[36] R K. pheatmap: Pretty Heatmaps. R package version 1.0.12. 2019. https://CRAN.R-project.org/package=pheatmap

[37] GustavssonEK, ZhangD, ReynoldsRH, Garcia-Ruiz S, RytenM. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics. 2022;38(15):3844-3846.

[38] SubramanianA, TamayoP, MoothaVK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545-15550.

[39] YuG, WangLG, HanY, HeQY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS: J Integr Biol. 2012;16(5):284-287.

[40] MorganMFS, Gentleman R. GSEABase: gene set enrichment data structures and methods. R package version 1.66.0. 2024. https://bioconductor.org/packages/GSEABase

[41] G. Y. Enrichplot: visualization of functional enrichment result. R package version 1.24.4. 2024. https://bioconductor.org/packages/enrichplot

[42] Warde-FarleyD, Donaldson SL, ComesO, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214-W220.

[43] FranzM, Rodriguez H, LopesC, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60-W64.

[44] HanY, ChenK, YuH, et al. Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer’s disease. Brain. 2024;147:2128-2143.

[45] BowdenJ, Del Greco MF, MinelliC, Davey SmithG, Sheehan N, ThompsonJ. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36(11):1783-1802.

[46] Huedo-MedinaTB, Sánchez-Meca J, Marín-Martínez F, BotellaJ. Assessing heterogeneity in meta-analysis: Q statistic or I² index? Psychol Methods. 2006;11(2):193-206.

[47] BowdenJ, Davey Smith G, BurgessS. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512-525.

[48] MaJ, ChenT, WuS, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47(D1):D1211-D1217.

[49] ChenT, MaJ, LiuY, et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 2022;50(D1):D1522-D1527.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm - Future Medicine published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA).